This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Full Automaticity and Remote Follow-up

This study has been completed.
Information provided by (Responsible Party):
Medtronic Bakken Research Center Identifier:
First received: November 14, 2011
Last updated: April 18, 2017
Last verified: February 2017

With the expansion of Sudden Cardiac Death (SCD) primary prevention indications, the number of Implantable Cardioverter Defibrillators (ICD) implants has increased significantly in the recent years. This has resulted in an increase of the number of follow-up (FU) to be performed and a growing workload for centers. Remote FU system such as the Medtronic Carelink system allows to check remotely the proper functioning of self evaluating devices and give informations of some clinical events.

The objective of this study is to define which patients with a remote follow-up need additional onsite visit and to assess to which extent remote FU can be an alternative to onsite visit.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Identification of Implantable Cardioverter Defibrillator Patients With Remote Follow up That Requires an Onsite Visit

Further study details as provided by Medtronic Bakken Research Center:

Primary Outcome Measures:
  • Remote Follow-up as an Alternative to Onsite Visit [ Time Frame: 13 months ]
    Evaluate the percentage of patients who had a successful remote follow up, as an alternative to onsite visit for patients implanted with a fully automatic ICD

Enrollment: 354
Study Start Date: May 2011
Study Completion Date: March 2015
Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)
ICD patients with remote follow-up
Patients implanted with a fully automatic ICD and remotely followed-up.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient implanted with a sigle- or dual-chamber ICD or a Cardiac Resynchronization-Defibrillator system (CRT-D) and remotely followed-up

Inclusion Criteria:

  • Patient older than 18,
  • Patient implanted with a fully automatic ICD and remotely followed-up,
  • Patient geographically stable and able to attend FU at investigative site
  • Patient who signed a data release authorization form,

Exclusion Criteria:

  • Patient whose mental or physical capacity impedes to give an informed data release authorization,
  • Patient already enrolled in a clinical study whose procedures may interfere with the results of the present study,
  • Patients in New York Heart Association (NYHA) class IV
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01526629

CH Montfermeil
Montfermeil, France, 93370
Sponsors and Collaborators
Medtronic Bakken Research Center
Principal Investigator: Walid Amara, MD Centre Hospitalier de Montfermeil
  More Information

Responsible Party: Medtronic Bakken Research Center Identifier: NCT01526629     History of Changes
Other Study ID Numbers: 1047
Study First Received: November 14, 2011
Results First Received: February 14, 2017
Last Updated: April 18, 2017

Keywords provided by Medtronic Bakken Research Center:
Remote follow-up

Additional relevant MeSH terms:
Arrhythmias, Cardiac
Heart Diseases
Cardiovascular Diseases
Pathologic Processes processed this record on August 17, 2017